272 related articles for article (PubMed ID: 28872272)
1. Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa.
Bock P; Phiri C; Piwowar-Manning E; Kosloff B; Mandla N; Young A; James A; Schaap A; Scheepers M; Donnell D; Griffith S; El-Sadr W; Shanaube K; Beyers N; Hayes R; Fidler S; Ayles H;
J Int AIDS Soc; 2017 Aug; 20(Suppl 6):21780. PubMed ID: 28872272
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
[TBL] [Abstract][Full Text] [Related]
3. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
[TBL] [Abstract][Full Text] [Related]
4. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
Hayes R; Floyd S; Schaap A; Shanaube K; Bock P; Sabapathy K; Griffith S; Donnell D; Piwowar-Manning E; El-Sadr W; Beyers N; Ayles H; Fidler S;
PLoS Med; 2017 May; 14(5):e1002292. PubMed ID: 28464041
[TBL] [Abstract][Full Text] [Related]
5. Assessment of a screening tool to aid home-based identification of adolescents (aged 10-14) living with HIV in Zambia and South Africa: HPTN 071 (PopART) study.
Chaila MJ; Mcleod D; Vermund SH; Mbolongwe-Thornicroft M; Mbewe M; Mubekapi-Musadaidzwa C; Harper A; Schaap A; Floyd S; Hoddinott G; Hayes R; Fidler S; Ayles H; Shanaube K;
PLoS One; 2024; 19(2):e0266573. PubMed ID: 38363733
[TBL] [Abstract][Full Text] [Related]
6. Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.
Floyd S; Ayles H; Schaap A; Shanaube K; MacLeod D; Phiri M; Griffith S; Bock P; Beyers N; Fidler S; Hayes R;
PLoS One; 2018; 13(8):e0197904. PubMed ID: 30096139
[TBL] [Abstract][Full Text] [Related]
7. Social response to the delivery of HIV self-testing in households: experiences from four Zambian HPTN 071 (PopART) urban communities.
Bwalya C; Simwinga M; Hensen B; Gwanu L; Hang'andu A; Mulubwa C; Phiri M; Hayes R; Fidler S; Mwinga A; Ayles H; Bond V;
AIDS Res Ther; 2020 Jun; 17(1):32. PubMed ID: 32527261
[TBL] [Abstract][Full Text] [Related]
8. Closing the gap: did delivery approaches complementary to home-based testing reach men with HIV testing services during and after the HPTN 071 (PopART) trial in Zambia?
Phiri MM; Schaap A; Simwinga M; Hensen B; Floyd S; Mulubwa C; Simuyaba M; Chiti B; Bond V; Shanaube K; Fidler S; Hayes R; Ayles H;
J Int AIDS Soc; 2022 Jan; 25(1):e25855. PubMed ID: 35001530
[TBL] [Abstract][Full Text] [Related]
9. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
[TBL] [Abstract][Full Text] [Related]
10. Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial.
Telisinghe L; Floyd S; MacLeod D; Schaap A; Dunbar R; Bwalya J; Bell-Mandla N; Piwowar-Manning E; Donnell D; Shaunaube K; Bock P; Fidler S; Hayes RJ; Ayles HM;
PLoS Med; 2024 May; 21(5):e1004393. PubMed ID: 38820246
[TBL] [Abstract][Full Text] [Related]
11. Who Accepts and Who Uses Community-Based Secondary Distribution HIV Self-Testing (HIVST) Kits? Findings From the Intervention Arm of a Cluster-Randomized Trial of HIVST Distribution Nested in Four HPTN 071 (PopART) Communities in Zambia.
Hensen B; Schaap AJ; Mulubwa C; Floyd S; Shanaube K; Phiri MM; Bond V; Bwalya C; Simwinga M; Fidler S; Hayes R; Mwinga A; Ayles H
J Acquir Immune Defic Syndr; 2020 Aug; 84(4):355-364. PubMed ID: 32195749
[TBL] [Abstract][Full Text] [Related]
12. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial.
Hayes R; Ayles H; Beyers N; Sabapathy K; Floyd S; Shanaube K; Bock P; Griffith S; Moore A; Watson-Jones D; Fraser C; Vermund SH; Fidler S;
Trials; 2014 Feb; 15():57. PubMed ID: 24524229
[TBL] [Abstract][Full Text] [Related]
13. Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).
Hayes RJ; Donnell D; Floyd S; Mandla N; Bwalya J; Sabapathy K; Yang B; Phiri M; Schaap A; Eshleman SH; Piwowar-Manning E; Kosloff B; James A; Skalland T; Wilson E; Emel L; Macleod D; Dunbar R; Simwinga M; Makola N; Bond V; Hoddinott G; Moore A; Griffith S; Deshmane Sista N; Vermund SH; El-Sadr W; Burns DN; Hargreaves JR; Hauck K; Fraser C; Shanaube K; Bock P; Beyers N; Ayles H; Fidler S;
N Engl J Med; 2019 Jul; 381(3):207-218. PubMed ID: 31314965
[TBL] [Abstract][Full Text] [Related]
14. Community based distribution of oral HIV self-testing kits in Zambia: a cluster-randomised trial nested in four HPTN 071 (PopART) intervention communities.
Mulubwa C; Hensen B; Phiri MM; Shanaube K; Schaap AJ; Floyd S; Phiri CR; Bwalya C; Bond V; Simwinga M; Mwenge L; Fidler S; Hayes R; Mwinga A; Ayles H;
Lancet HIV; 2019 Feb; 6(2):e81-e92. PubMed ID: 30584047
[TBL] [Abstract][Full Text] [Related]
15. HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa.
Hargreaves JR; Stangl A; Bond V; Hoddinott G; Krishnaratne S; Mathema H; Moyo M; Viljoen L; Brady L; Sievwright K; Horn L; Sabapathy K; Ayles H; Beyers N; Bock P; Fidler S; Griffith S; Seeley J; Hayes R;
Health Policy Plan; 2016 Dec; 31(10):1342-1354. PubMed ID: 27375126
[TBL] [Abstract][Full Text] [Related]
16. Households, fluidity, and HIV service delivery in Zambia and South Africa - an exploratory analysis of longitudinal qualitative data from the HPTN 071 (PopART) trial.
Hoddinott G; Myburgh H; de Villiers L; Ndubani R; Mantantana J; Thomas A; Mbewe M; Ayles H; Bock P; Seeley J; Shanaube K; Hargreaves J; Bond V; Reynolds L;
J Int AIDS Soc; 2018 Jul; 21 Suppl 4(Suppl Suppl 4):e25135. PubMed ID: 30027687
[TBL] [Abstract][Full Text] [Related]
17. Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART).
Eshleman SH; Piwowar-Manning E; Wilson EA; Lennon D; Fogel JM; Agyei Y; Sullivan PA; Weng L; Moore A; Laeyendecker O; Kosloff B; Bwalya J; Maarman G; van Deventer A; Floyd S; Bock P; Ayles H; Fidler S; Hayes R; Donnell D;
J Int AIDS Soc; 2020 Feb; 23(2):e25452. PubMed ID: 32072743
[TBL] [Abstract][Full Text] [Related]
18. Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.
Vermund SH; Fidler SJ; Ayles H; Beyers N; Hayes RJ
J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S221-7. PubMed ID: 23764639
[TBL] [Abstract][Full Text] [Related]
19. Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial.
Wilson E; Donnell D; Skalland T; Floyd S; Moore A; Bell-Mandla N; Bwalya J; Kasese N; Dunbar R; Shanaube K; Kosloff B; Laeyendecker O; Agyei Y; Hoddinott G; Bock P; Fidler S; Hayes R; Ayles H;
Lancet HIV; 2022 Nov; 9(11):e760-e770. PubMed ID: 36332653
[TBL] [Abstract][Full Text] [Related]
20. Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis.
Macleod D; Shanaube K; Skalland T; Limbada M; Mandla N; Bwalya J; Schaap A; Yang B; Donnell D; Piwowar-Manning E; Eshleman SH; Hoddinott G; Bond V; Moore A; Griffith S; Bock P; Ayles H; Fidler S; Hayes R; Floyd S;
Lancet HIV; 2022 Nov; 9(11):e751-e759. PubMed ID: 36332652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
